Clinical Trial Update: Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial evaluating everolimus (RAD001) as monotherapy for advanced cholangiocarcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Ratchavithi Hospital | Conditions: Cholangiocarcinoma | Phase 2 | Status: UNKNOWN